Fulcrum Therapeutics Statistics
Total Valuation
FULC has a market cap or net worth of $287.96 million. The enterprise value is -$11.76 million.
| Market Cap | 287.96M |
| Enterprise Value | -11.76M |
Important Dates
The last earnings date was Thursday, November 12, 2026, after market close.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FULC has 76.38 million shares outstanding. The number of shares has increased by 18.34% in one year.
| Current Share Class | 76.38M |
| Shares Outstanding | 76.38M |
| Shares Change (YoY) | +18.34% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 1.03% |
| Owned by Institutions (%) | 85.14% |
| Float | 63.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.95 |
| P/TBV Ratio | 0.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 36.19, with a Debt / Equity ratio of 0.02.
| Current Ratio | 36.19 |
| Quick Ratio | 35.85 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -30.51% and return on invested capital (ROIC) is -18.54%.
| Return on Equity (ROE) | -30.51% |
| Return on Assets (ROA) | -18.13% |
| Return on Invested Capital (ROIC) | -18.54% |
| Return on Capital Employed (ROCE) | -25.23% |
| Weighted Average Cost of Capital (WACC) | 19.04% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$8.48M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.90% in the last 52 weeks. The beta is 2.77, so FULC's price volatility has been higher than the market average.
| Beta (5Y) | 2.77 |
| 52-Week Price Change | -54.90% |
| 50-Day Moving Average | 3.73 |
| 200-Day Moving Average | 5.52 |
| Relative Strength Index (RSI) | 54.90 |
| Average Volume (20 Days) | 1,298,984 |
Short Selling Information
The latest short interest is 6.44 million, so 8.43% of the outstanding shares have been sold short.
| Short Interest | 6.44M |
| Short Previous Month | 6.76M |
| Short % of Shares Out | 8.43% |
| Short % of Float | 10.15% |
| Short Ratio (days to cover) | 4.52 |
Income Statement
| Revenue | n/a |
| Gross Profit | -44.98M |
| Operating Income | -76.25M |
| Pretax Income | -76.34M |
| Net Income | -76.34M |
| EBITDA | -75.35M |
| EBIT | -76.25M |
| Earnings Per Share (EPS) | -$1.04 |
Balance Sheet
The company has $306.55 million in cash and $6.83 million in debt, with a net cash position of $299.72 million or $3.92 per share.
| Cash & Cash Equivalents | 306.55M |
| Total Debt | 6.83M |
| Net Cash | 299.72M |
| Net Cash Per Share | $3.92 |
| Equity (Book Value) | 302.03M |
| Book Value Per Share | 3.95 |
| Working Capital | 302.22M |
Cash Flow
In the last 12 months, operating cash flow was -$64.97 million and capital expenditures -$275,000, giving a free cash flow of -$65.24 million.
| Operating Cash Flow | -64.97M |
| Capital Expenditures | -275,000 |
| Depreciation & Amortization | 901,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -65.24M |
| FCF Per Share | -$0.85 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FULC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -18.34% |
| Shareholder Yield | -18.34% |
| Earnings Yield | -27.49% |
| FCF Yield | -22.66% |
Analyst Forecast
The average price target for FULC is $3.67, which is -2.73% lower than the current price. The consensus rating is "Hold".
| Price Target | $3.67 |
| Price Target Difference | -2.73% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |